InMode (INMD) Competitors $15.16 -0.06 (-0.36%) Closing price 07/3/2025 03:31 PM EasternExtended Trading$15.16 +0.01 (+0.03%) As of 07/3/2025 04:57 PM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more. Add Compare Share Share Competitors Stock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesOptions ChainOwnershipSEC FilingsShort InterestTrendsBuy This Stock INMD vs. NVST, PRCT, LIVN, WRBY, NVCR, LMAT, EYE, ENOV, CNMD, and AORTShould you be buying InMode stock or one of its competitors? The main competitors of InMode include Envista (NVST), PROCEPT BioRobotics (PRCT), LivaNova (LIVN), Warby Parker (WRBY), NovoCure (NVCR), LeMaitre Vascular (LMAT), National Vision (EYE), Enovis (ENOV), CONMED (CNMD), and Artivion (AORT). These companies are all part of the "medical equipment" industry. InMode vs. Its Competitors Envista PROCEPT BioRobotics LivaNova Warby Parker NovoCure LeMaitre Vascular National Vision Enovis CONMED Artivion Envista (NYSE:NVST) and InMode (NASDAQ:INMD) are both medical companies, but which is the superior business? We will contrast the two businesses based on the strength of their risk, media sentiment, dividends, profitability, earnings, analyst recommendations, valuation and institutional ownership. Do analysts prefer NVST or INMD? Envista currently has a consensus target price of $20.23, indicating a potential downside of 0.78%. InMode has a consensus target price of $18.54, indicating a potential upside of 22.35%. Given InMode's higher probable upside, analysts clearly believe InMode is more favorable than Envista.Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score Envista 1 Sell rating(s) 9 Hold rating(s) 4 Buy rating(s) 1 Strong Buy rating(s) 2.33InMode 0 Sell rating(s) 7 Hold rating(s) 1 Buy rating(s) 0 Strong Buy rating(s) 2.13 Which has better earnings & valuation, NVST or INMD? InMode has lower revenue, but higher earnings than Envista. Envista is trading at a lower price-to-earnings ratio than InMode, indicating that it is currently the more affordable of the two stocks. CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings RatioEnvista$2.51B1.38-$1.12B-$6.53-3.12InMode$394.82M2.43$181.27M$2.336.50 Does the media prefer NVST or INMD? In the previous week, Envista had 3 more articles in the media than InMode. MarketBeat recorded 5 mentions for Envista and 2 mentions for InMode. InMode's average media sentiment score of 1.59 beat Envista's score of 1.03 indicating that InMode is being referred to more favorably in the news media. Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment Envista 3 Very Positive mention(s) 0 Positive mention(s) 2 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Positive InMode 2 Very Positive mention(s) 0 Positive mention(s) 0 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Very Positive Do insiders & institutionals have more ownership in NVST or INMD? 68.0% of InMode shares are owned by institutional investors. 1.3% of Envista shares are owned by company insiders. Comparatively, 6.9% of InMode shares are owned by company insiders. Strong institutional ownership is an indication that hedge funds, endowments and large money managers believe a company will outperform the market over the long term. Which has more volatility & risk, NVST or INMD? Envista has a beta of 1, indicating that its share price has a similar volatility profile to the S&P 500.Comparatively, InMode has a beta of 1.95, indicating that its share price is 95% more volatile than the S&P 500. Is NVST or INMD more profitable? InMode has a net margin of 44.79% compared to Envista's net margin of -44.90%. InMode's return on equity of 17.17% beat Envista's return on equity.Company Net Margins Return on Equity Return on Assets Envista-44.90% 4.07% 2.25% InMode 44.79%17.17%15.20% SummaryInMode beats Envista on 11 of the 17 factors compared between the two stocks. Get InMode News Delivered to You Automatically Sign up to receive the latest news and ratings for INMD and its competitors with MarketBeat's FREE daily newsletter. Email Address New MarketBeat Followers Over TimeWhat are MarkeBeat Followers?This chart shows the number of new MarketBeat users adding INMD and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period. Skip ChartMedia Sentiment Over TimeWhat is Media Sentiment?This chart shows the average media sentiment of NASDAQ and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.Skip Chart INMD vs. The Competition Export to ExcelMetricInModeMED PRODUCTS IndustryMedical SectorNASDAQ ExchangeMarket Cap$958.25M$10.52B$5.56B$9.05BDividend YieldN/A2.07%5.24%3.99%P/E Ratio6.5011.3219.9620.26Price / Sales2.4329.81419.56119.26Price / Cash8.3123.9726.2128.59Price / Book1.503.668.035.65Net Income$181.27M$235.43M$3.18B$249.15M7 Day Performance6.80%2.15%2.93%3.28%1 Month Performance7.03%1.07%1.72%3.95%1 Year Performance-12.75%-10.17%34.39%20.98% InMode Competitors List Export to ExcelCompanyMarketRankShare PriceAnalysts' Price Target1Y Price PerformanceMarket CapRevenueP/E RatioEmployee CountIndicator(s)INMDInMode3.3351 of 5 stars$15.16-0.4%$18.54+22.3%-12.8%$958.25M$394.82M6.50480NVSTEnvista3.7777 of 5 stars$19.58-0.5%$20.23+3.3%+24.3%$3.32B$2.51B-3.0012,300News CoveragePRCTPROCEPT BioRobotics2.4315 of 5 stars$57.60+1.2%$90.00+56.3%-8.8%$3.19B$224.50M-33.88430News CoverageLIVNLivaNova3.219 of 5 stars$45.02-1.6%$59.29+31.7%-12.1%$2.45B$1.25B-11.012,900News CoveragePositive NewsWRBYWarby Parker2.1868 of 5 stars$21.94+0.2%$22.88+4.3%+41.5%$2.29B$771.32M-182.833,780NVCRNovoCure3.6096 of 5 stars$17.80-1.1%$32.83+84.5%+5.5%$1.98B$605.22M-11.791,488LMATLeMaitre Vascular2.4353 of 5 stars$83.05+0.6%$97.83+17.8%+1.5%$1.88B$219.86M41.94490EYENational Vision2.6285 of 5 stars$23.01-0.7%$18.67-18.9%+94.9%$1.82B$1.85B-69.7313,411News CoverageENOVEnovis3.5822 of 5 stars$31.36-1.3%$58.00+84.9%-25.0%$1.79B$2.11B-2.257,367Positive NewsCNMDCONMED4.5819 of 5 stars$52.10-0.1%$62.20+19.4%-21.1%$1.61B$1.31B13.713,900AORTArtivion2.482 of 5 stars$31.17-0.1%$32.00+2.7%+21.7%$1.33B$388.54M-62.341,600 Related Companies and Tools Related Companies NVST Alternatives PRCT Alternatives LIVN Alternatives WRBY Alternatives NVCR Alternatives LMAT Alternatives EYE Alternatives ENOV Alternatives CNMD Alternatives AORT Alternatives Top 10 Stock Comparisons Semiconductor Stocks Artificial Intelligence Stocks Growth Stocks Magnificent Seven Stocks Pharmaceutical Stocks Ecommerce Stocks Bitcoin Stocks Meme Stocks Cryptocurrency Stocks Cybersecurity Stocks This page (NASDAQ:INMD) was last updated on 7/6/2025 by MarketBeat.com Staff From Our PartnersINVESTOR ALERT: Tiny “$3 AI Wonder Stock” on the Verge of Blasting OffRight now, we’re witnessing a monumental shift in the world.Traders Agency | SponsoredEveryone’s watching Nvidia right now. Here’s why I’m excited.So, unless you’ve been living under a rock, you probably saw the news… Nvidia just signed a $7 BILLION deal...Timothy Sykes | SponsoredThis Signal Only Flashes Once Every 4 Years – And It Just TriggeredThis same signal has appeared twice before in the past 8 years — both times, it kicked off major moves in cryp...Crypto Swap Profits | SponsoredPresidential Bombshell: $150T Resource to Be Released as soon as this Summer?Something extraordinary is happening in Washington. For the first time in over a century, a sitting Preside...Paradigm Press | SponsoredDalio heeds Buffett’s warning… [$319 million stake in gold]Dalio bought a gold ETF… I don’t recommend that for the average retail investor. The real upside is in profita...Golden Portfolio | SponsoredElon’s RevengeElon Musk and President Trump's new feud is all over the news... But what no one has reported – yet – is th...Altimetry | SponsoredGold buying hits 4-year highThe perfect gold play right now? (currently under $10) Everything in the news now lines up perfectly for an...Stansberry Research | SponsoredTrump's ticking time bombA looming tariff deadline on July 9th could be the spark — but what’s buried inside a recent White House docum...Porter & Company | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added ten stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding InMode Ltd. Please log in to your account or sign up in order to add this asset to your watchlist. Share InMode With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
Free INMD Stock Alerts